Calciphylaxis associated with end stage kidney disease’s patient and low bone turnover: A case report

Main Article Content

Nijjaree Jirachiefpattana
Wanaphon Methaprayoon
Wasakorn Bunyayothin
Wannasit Wathanavasin

Abstract

Calciphylaxis is an uncommon and potentially life-threatening condition of vascular calcification in end-stage kidney disease characterized by the occlusion of micro vessels in the subcutaneous fat and dermis. It is usually associated with poorly controlled chronic kidney disease associated mineral and bone disorders. Early recognition of calciphylaxis relies on heightened clinical awareness of the presence of painful skin lesions in an adipose tissue-rich area. Here we report the case of a hemodialysis patient with low turnover disease who presented with chronic, non-resolving, painful ulcers on the left thigh and left leg for 2 months. Prompt multi-modal treatment and a multi-disciplinary approach were taken together to prevent the devastating outcome. However, our patient denied invasive surgical intervention, causing fatal septicemia. This case emphasizes that early identification and surgical intervention are important to avoid the high morbidity and mortality associated with calciphylaxis.

Article Details

How to Cite
Jirachiefpattana, N., Methaprayoon, W., Bunyayothin, W., & Wathanavasin, W. (2025). Calciphylaxis associated with end stage kidney disease’s patient and low bone turnover: A case report. Journal of Charoenkrung Pracharak Hospital, 21(2), 180–194. retrieved from https://he02.tci-thaijo.org/index.php/JCP/article/view/273240
Section
Case Report

References

Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant 2017;32(1):126-32.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011) 2017;7(1):1-59.

McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc 2016;91(10):1384-94.

Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol 2016;27(11):3421-9.

Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002;61(6):2210-7.

Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007;56(4):569-79.

Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med 2018;378(18):1704-14.

Storan ER, O'Gorman SM, Murphy A, Laing M. Case report of calciphylaxis secondary to calcium and vitamin D3 supplementation. J Cutan Med Surg 2017;21(2):162-3.

Chang JJ. Calciphylaxis: diagnosis, pathogenesis, and treatment. Adv Skin Wound Care 2019;32(5):205-15.

Zitt E, Konig M, Vychytil A, Auinger M, Wallner M, Lingenhel G, et al. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant 2013;28(5):1232-40.

Shigematsu T, Tokumoto A, Nakaoka A, Arisaka H. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial 2011;15(2):176-84.

Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Levesque R, Nube MJ, et al. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled convective transport study (CONTRAST). Am J Kidney Dis 2010;55(1):77-87.

Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L. Calciphylaxis and kidney disease: a review. Am J Kidney Dis 2023;81(2):232-9.

Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol 2013;8(7):1162-70.

Shioi A, Morioka T, Shoji T, Emoto M. The inhibitory roles of vitamin K in progression of vascular calcification. Nutrients 2020;12(2):583.

Wajih Z, Singer R. Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis. Clin Kidney J 2021;15(2):354-6.

Arribas-Lopez E, Zand N, Ojo O, Snowden MJ, Kochhar T. The effect of amino acids on wound healing: a systematic review and meta-analysis on arginine and glutamine. Nutrients 2021;13(8):2498.